These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2970126)

  • 21. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
    Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
    Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fatal anuria after oral cholecystography].
    Perreau P; Joubaud F; Ben Bouali A; Riberi P; Bertrand G
    Sem Hop; 1972 Mar; 48(14):967-71. PubMed ID: 4339075
    [No Abstract]   [Full Text] [Related]  

  • 23. [Report on pathologico-anatomical and autoradiographic studies in 9 cases of human thorotrastosis].
    Wegener K; Zahnert R
    Virchows Arch A Pathol Pathol Anat; 1970; 351(4):316-32. PubMed ID: 4321534
    [No Abstract]   [Full Text] [Related]  

  • 24. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
    Djazayeri K; Szilvássy Z; Peitl B; Németh J; Nagy L; Kiss A; Szabó B; Benko I
    Eur J Pharmacol; 2005 Oct; 522(1-3):122-9. PubMed ID: 16213483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
    Chlebowski RT; Paroly WS; Pugh RP; Weiner JM; Bateman JR
    Cancer Treat Rep; 1979; 63(11-12):1979-81. PubMed ID: 393383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.
    Ducreux M; Dahan L; Smith D; O'Toole D; Lepère C; Dromain C; Vilgrain V; Baudin E; Lombard-Bohas C; Scoazec JY; Seitz JF; Bitoun L; Koné S; Mitry E
    Eur J Cancer; 2014 Dec; 50(18):3098-106. PubMed ID: 25454412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Foam cell syndrome in bone marrow].
    Miura A; Shibata A; Akihama T; Endo Y; Takahashi K
    Rinsho Ketsueki; 1972 Oct; 13(5):769-76. PubMed ID: 4577427
    [No Abstract]   [Full Text] [Related]  

  • 28. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
    Nyfors A
    Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gastrointestinal complications of tumor chemotherapy].
    Semendiaeva ME; Petrovskiĭ VS
    Sov Med; 1981; (7):70-6. PubMed ID: 7027466
    [No Abstract]   [Full Text] [Related]  

  • 31. Side-effects of phenindione.
    Copeman PW
    Br Med J; 1968 Aug; 3(5617):557. PubMed ID: 4234096
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):79-85. PubMed ID: 4213510
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxicity of 5-fluorouracil.
    Macdonald JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):33-4. PubMed ID: 10442356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of medroxyprogesterone acetate on antitumor efficacies and side effect of 5-fluorouracil].
    Ashizawa T; Ishida H; Okabe M; Gomi K
    Gan To Kagaku Ryoho; 1993 May; 20(7):941-7. PubMed ID: 8489300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diffuse liver necrosis in treatment with 5-fluorouracil].
    Vestfrid MA; Castelleto L; Giménez PO
    Rev Clin Esp; 1972 Jun; 125(6):549-50. PubMed ID: 5074970
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of the risk factors for myelosuppression after chemoradiotherapy involving 5-fluorouracil and platinum for patients with esophageal cancer.
    Kogo M; Watahiki M; Sunaga T; Kaneko K; Yoneyama K; Imawari M; Kiuchi Y
    Hepatogastroenterology; 2011; 58(107-108):802-8. PubMed ID: 21830394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute bone marrow and liver damage during treatment with clozapine].
    Brodowski L; Matusewicz W; Urbańska-Ryś H; Krykowski E
    Pol Tyg Lek; 1984 May; 39(21):721-2. PubMed ID: 6483677
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methotrexate/5-fluorouracil therapy in gastric cancer with peritoneal metastasis].
    Kosaka T; Sugaya J; Sejima T; Takano Y; Nakano Y; Akiyama T; Kiriyama M; Tomita F; Saito H; Kita I
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2266-9. PubMed ID: 7944456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow aplasia associated with ticlopidine therapy.
    Elias M; Reichman N; Flatau E
    Am J Hematol; 1993 Dec; 44(4):289-90. PubMed ID: 8238004
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
    Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
    Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.